Insulin Patch Pumps Market

The global insulin patch pumps market accounted for USD 1.01 billion in 2023 and is expected to reach USD 3.19 billion by 2034 with a CAGR of 10.97% during the forecast period 2024-2034. The market will grow as a result of factors such as the increasing prevalence of diabetes, the growing preference for non-invasive delivery systems, technological advancements, patient-centered care, and increased awareness and education.

More advanced and user-friendly insulin patch pumps have been developed as a result of ongoing technological breakthroughs. Nowadays, these pumps come equipped with functions like remote monitoring and control via mobile devices, automatic insulin delivery, and integration with continuous glucose monitoring systems. The need for insulin patch pumps is being driven by these technological advancements that enhance patient convenience, adherence, and overall diabetes care. For instance, in February 2024, Medtronic announced that its cutting-edge hybrid closed-loop insulin administration system, the MiniMedTM 780G system, would be available in the US.

By delivery mode, the basal and bolus delivery segment accounted for the highest revenue-grossing segment in the global insulin patch pumps market in 2023 owing to the increasing adoption of personalized insulin delivery regimens and the demand for precise and customizable insulin dosing among diabetic patients. For instance, Insulet declared in January 2024 that it has started a limited market rollout of its Omnipod 5 automated insulin administration device in the US. Additionally, the basal segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of diabetes and the need for continuous and stable insulin delivery, driving demand for basal insulin patch pumps for long-term management of the condition.

By product type, the disposable pumps segment accounted for the highest revenue-grossing segment in the global insulin patch pumps market in 2023 owing to the convenience, reduced risk of infection, and ease of use associated with disposable pumps, meeting the preferences of patients and healthcare providers for hassle-free insulin delivery solutions. For instance, Tandem Diabetes Care announced in February 2024 that it had entered into a distribution arrangement with Byram Healthcare, which would increase the availability of Tandem's insulin delivery solutions in the United States. Additionally, the reusable pumps segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for sustainable and cost-effective insulin delivery options, coupled with advancements in materials and technology improving the durability and usability of reusable pumps.

By distribution channel, the hospital's segment accounted for the highest revenue-grossing segment in the global insulin patch pumps market in 2023 owing to the increasing adoption of insulin patch pumps in hospital settings for managing diabetes in in-patients and for specialized treatments, driving significant revenue growth in this segment. For instance, Abbott extended the age range for the use of the continuous glucose monitoring system in December 2023 by announcing that the FreeStyle Libre 2 system was available for use in children in the United States between the ages of 4 and 17. Additionally, the online pharmacies segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing consumer preference for convenience, accessibility, and a wide range of product offerings, driving the shift towards online purchasing of insulin patch pumps.

North American region is anticipated to have the highest revenue share during the forecast period owing to the high adoption rates of advanced medical technologies, increasing prevalence of diabetes, robust healthcare infrastructure, and favorable reimbursement policies driving the demand for insulin patch pumps in the North American region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly increasing diabetic population, improving healthcare infrastructure, rising disposable incomes, and growing awareness about diabetes management, propelling the demand for insulin patch pumps in the Asia Pacific region. For instance, Ypsomed announced in December 2023 that its mylife YpsoPump insulin pump would go on market in the US.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

• Base Year: 2023
• Forecast Period: 2024-2034
• Study Coverage
• Market Forecast by Delivery Mode, Product Type, and Distribution Channel
• Market Forecast for 5 Regions and 17+ Countries
• North America (U.S. and Canada)
• Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
• Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
• Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
• MEA (South Africa, GCC, Rest of MEA)
• Exhaustive Company Profiles of the Top 10+ Major Market Players

Segmentation: Insulin Patch Pumps Market Report 2023 - 2034

Insulin Patch Pumps Market Analysis & Forecast by Delivery Mode 2023 - 2034 (Revenue USD Bn)

• Basal
• Bolus
• Basal & Bolus

Insulin Patch Pumps Market Analysis & Forecast by Product Type 2023 - 2034 (Revenue USD Bn)

• Disposable
• Reusable

Insulin Patch Pumps Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

• Hospitals
• Retail Pharmacies
• Private Clinics
• Online Pharmacies
• Others

Insulin Patch Pumps Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of LATAM
• Middle East & Africa
• South Africa
• GCC
• Rest of MEA